Skip to content

Treatment of Patellar Chondromalacia through Physical Exercises

Exercises Therapy in Patellar Chondromalacia: A randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7d492mg
Enrollment
Unknown
Registered
2023-10-20
Start date
2023-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chondromalacia Patellae

Interventions

The entire randomization process will be conducted using the application (Randomizer for Clinic® MEDSHARING, version 1.4) and will be overseen by an administrative technician who will have no affiliat

Sponsors

Universidade Comunitária de Região de Chapecó
Lead Sponsor
Universidade Comunitária de Região de Chapecó
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Participants of both genders. Aged between 18 and 45 years. With a clinical diagnosis of patellar chondromalacia (grades I, II, III, and IV according to the classification of the International Cartilage Repair Society - ICRS)

Exclusion criteria

Exclusion criteria: Participants who have undergone recent surgical procedures (in the last three months). Peripheral vascular disease diagnosis. Diagnosis of hypertension. History of deep vein thrombosis or pulmonary embolism. Currently on anticoagulants. Previous history of myocardial infarction or prior stroke. Currently using type II collagen or chondroprotective agents. Patients who report knee joint injections in the last six months. Those with any type of gait alteration or difficulty. Lower limb deformity or axis deviation. Ligamentous or meniscal injuries

Design outcomes

Primary

MeasureTime frame
To assess the patellar cartilage thickness through images obtained from magnetic resonance imaging (MRI) of the knee joint at the beginning and end of the study. Preservation or an increase in cartilage thickness is expected following the intervention protocols.;The expectation is to observe an approximately 5% increase in blood concentrations of CTX-II at the conclusion of the interventions.;reduction in pain associated with chondromalacia patella (assessed by the visual analogue scale) of more than 30% is expected among patients after the interventions.

Secondary

MeasureTime frame
Maximum dynamic strength, assessed by the one repetition maximum test (1-RM), proposed by Brown and Weir (2001), should increase by around 50% in response to the proposed interventions.;Improvements in the perception of quality of life (greater than 5%), assessed by the Lequesne questionnaire (2006), considering pain, gait and joint stiffness are expected.

Countries

Brazil

Contacts

Public ContactClodoaldo De Sá

Universidade Comunitária de Região de Chapecó

clodoaldo@unochapeco.edu.br+55 (49) 3321-8215

Outcome results

None listed

Source: REBEC (via WHO ICTRP)